Published in Stem Cells Dev on August 26, 2011
Molecular and functional properties of P2X receptors--recent progress and persisting challenges. Purinergic Signal (2012) 1.31
Mechanisms underlying the osteo- and adipo-differentiation of human mesenchymal stem cells. ScientificWorldJournal (2012) 1.09
Calcium phosphate-bearing matrices induce osteogenic differentiation of stem cells through adenosine signaling. Proc Natl Acad Sci U S A (2014) 1.08
G protein-coupled adenosine (P1) and P2Y receptors: ligand design and receptor interactions. Purinergic Signal (2012) 1.00
Purinergic signalling in the musculoskeletal system. Purinergic Signal (2013) 0.93
Role of Hox genes in stem cell differentiation. World J Stem Cells (2015) 0.91
Extracellular ATP released by osteoblasts is a key local inhibitor of bone mineralisation. PLoS One (2013) 0.91
P2X7 Receptor Function in Bone-Related Cancer. J Osteoporos (2012) 0.89
Purinergic receptors and nucleotide processing ectoenzymes: Their roles in regulating mesenchymal stem cell functions. World J Stem Cells (2014) 0.89
Loss of P2X7 nucleotide receptor function leads to abnormal fat distribution in mice. Purinergic Signal (2013) 0.86
Differentiation of adipose-derived stem cells into Schwann cell phenotype induces expression of P2X receptors that control cell death. Cell Death Dis (2013) 0.83
Purinergic signaling: a common pathway for neural and mesenchymal stem cell maintenance and differentiation. Front Cell Neurosci (2015) 0.82
Retracted Phosphatase and tensin homolog deleted on chromosome 10 (PTEN) and PH domain and leucine-rich repeat phosphatase cross-talk (PHLPP) in cancer cells and in transforming growth factor β-activated stem cells. J Biol Chem (2014) 0.79
The role of purinergic receptors in stem cell differentiation. Comput Struct Biotechnol J (2014) 0.78
The influence of simulated microgravity on purinergic signaling is different between individual culture and endothelial and smooth muscle cell coculture. Biomed Res Int (2014) 0.78
Control of bone development by P2X and P2Y receptors expressed in mesenchymal and hematopoietic cells. Gene (2015) 0.77
Expression and function of P2 receptors in hematopoietic stem and progenitor cells. Stem Cell Investig (2015) 0.77
Transient receptor potential melastatin 4 channel controls calcium signals and dental follicle stem cell differentiation. Stem Cells (2013) 0.77
Purinergic signalling is required for calcium oscillations in migratory chondrogenic progenitor cells. Pflugers Arch (2014) 0.76
Activation, homing, and role of the mesenchymal stem cells in the inflammatory environment. J Inflamm Res (2016) 0.76
Clinical Observation of Employment of Umbilical Cord Derived Mesenchymal Stem Cell for Juvenile Idiopathic Arthritis Therapy. Stem Cells Int (2015) 0.76
Stem Cells on Biomaterials for Synthetic Grafts to Promote Vascular Healing. J Clin Med (2014) 0.76
Regulation of the osteogenic and adipogenic differentiation of bone marrow-derived stromal cells by extracellular uridine triphosphate: The role of P2Y2 receptor and ERK1/2 signaling. Int J Mol Med (2015) 0.75
ATP-induced Ca(2+)-signalling mechanisms in the regulation of mesenchymal stem cell migration. Cell Mol Life Sci (2017) 0.75
Role of radiotherapy in supratentorial primitive neuroectodermal tumor in young children: results of the German HIT-SKK87 and HIT-SKK92 trials. J Clin Oncol (2006) 1.73
Long-term outcome and clinical prognostic factors in children with medulloblastoma treated in the prospective randomised multicentre trial HIT'91. Eur J Cancer (2009) 1.70
Heme oxygenase-1-derived carbon monoxide requires the activation of transcription factor NF-kappa B to protect endothelial cells from tumor necrosis factor-alpha-mediated apoptosis. J Biol Chem (2002) 1.68
Diagnostic and prognostic impact of urinary catecholamines in neuroblastoma patients. Pediatr Blood Cancer (2007) 1.65
"Wait and see" strategy in localized neuroblastoma in infants: an option not only for cases detected by mass screening. Pediatr Blood Cancer (2004) 1.62
Treatment results of childhood acute lymphoblastic leukemia in Austria--a report of 20 years' experience. Wien Klin Wochenschr (2002) 1.43
Treatment for soft tissue sarcoma in childhood and adolescence. Austrian results within the CWS 96 study. Wien Klin Wochenschr (2005) 1.39
Discovery of potent and selective agonists for the free fatty acid receptor 1 (FFA(1)/GPR40), a potential target for the treatment of type II diabetes. J Med Chem (2008) 1.25
Prognostic relevance of clinical and biological risk factors in childhood medulloblastoma: results of patients treated in the prospective multicenter trial HIT'91. Clin Cancer Res (2007) 1.18
Charge-transfer-induced structural rearrangements at both sides of organic/metal interfaces. Nat Chem (2010) 1.16
Hemophagocytic lymphohistiocytosis as severe adverse event of antineoplastic treatment in children. Haematologica (2008) 1.13
Mechanisms underlying the osteo- and adipo-differentiation of human mesenchymal stem cells. ScientificWorldJournal (2012) 1.09
Free fatty acid receptor 1 (FFA1/GPR40) agonists: mesylpropoxy appendage lowers lipophilicity and improves ADME properties. J Med Chem (2012) 1.06
Transplantation of CD3/CD19 depleted allografts from haploidentical family donors in paediatric leukaemia. Br J Haematol (2014) 1.05
Cadmium and mitochondria. Mitochondrion (2009) 1.05
IL-17 reduces TNF-induced Rantes and VCAM-1 expression. Cytokine (2005) 1.04
Identification of a potent and selective free fatty acid receptor 1 (FFA1/GPR40) agonist with favorable physicochemical and in vitro ADME properties. J Med Chem (2011) 1.03
Carbon monoxide protects pancreatic beta-cells from apoptosis and improves islet function/survival after transplantation. Diabetes (2002) 1.00
Modulation of endothelial cell apoptosis by heme oxygenase-1-derived carbon monoxide. Antioxid Redox Signal (2002) 1.00
Differentiation potential of adult human mesenchymal stem cells. Clin Lab (2007) 1.00
Preradiation chemotherapy for pediatric patients with high-grade glioma. Cancer (2002) 1.00
Fusarium verticillioides abscess of the nasal septum in an immunosuppressed child: case report and identification of the morphologically atypical fungal strain. J Clin Microbiol (2005) 0.97
Survival and late effects in children with stage 4 neuroblastoma. Pediatr Blood Cancer (2011) 0.97
C-reactive protein (CRP) as tumor marker in pediatric and adolescent patients with Hodgkin disease. Med Pediatr Oncol (2003) 0.96
Successful treatment of progressive cutaneous mastocytosis with imatinib in a 2-year-old boy carrying a somatic KIT mutation. Blood (2008) 0.95
Long-term outcome of initially homogenously treated and relapsed childhood acute lymphoblastic leukaemia in Austria--a population-based report of the Austrian Berlin-Frankfurt-Münster (BFM) Study Group. Br J Haematol (2008) 0.94
European Organization for the Research and Treatment of Cancer/Mycoses Study Group (EORTC/MSG) host factors and invasive fungal infections in patients with haematological malignancies. J Antimicrob Chemother (2012) 0.93
Aseptic osteonecrosis in children and adolescents treated for hemato-oncologic diseases: a 13-year longitudinal observational study. J Pediatr Hematol Oncol (2005) 0.92
Findings and clinical course of a localized primitive peripheral neuroectodermal tumor of the kidney. Urol Int (2003) 0.92
Intracerebral cavernous hemangioma after cranial irradiation in childhood. Incidence and risk factors. Strahlenther Onkol (2008) 0.91
Multimodal treatment of children with unresectable or recurrent desmoid tumors: an 11-year longitudinal observational study. J Pediatr Hematol Oncol (2004) 0.91
Outcome of children with primary resistant or relapsed non-Hodgkin lymphoma and mature B-cell leukemia after intensive first-line treatment: a population-based analysis of the Austrian Cooperative Study Group. Pediatr Blood Cancer (2005) 0.90
Gastrointestinal stromal tumours in children and young adults: a clinicopathologic series with long-term follow-up from the database of the Cooperative Weichteilsarkom Studiengruppe (CWS). Eur J Cancer (2011) 0.89
Outcome of children and adolescents with a second or third relapse of acute lymphoblastic leukemia (ALL): a population-based analysis of the Austrian ALL-BFM (Berlin-Frankfurt-Münster) study group. J Pediatr Hematol Oncol (2013) 0.88
Feasibility and toxicity of intrathecal liposomal cytarabine in 5 children and young adults with refractory neoplastic meningitis. J Pediatr Hematol Oncol (2007) 0.88
Interferon alfa-2a in recurrent metastatic hemangiopericytoma. Med Pediatr Oncol (2003) 0.87
Discovery of TUG-770: A Highly Potent Free Fatty Acid Receptor 1 (FFA1/GPR40) Agonist for Treatment of Type 2 Diabetes. ACS Med Chem Lett (2013) 0.87
Recurrent Pott's puffy tumor - atypical presentation of a rare disorder. Wien Klin Wochenschr (2009) 0.86
Late sequela after treatment of childhood low-grade gliomas: a retrospective analysis of 69 long-term survivors treated between 1983 and 2003. J Neurooncol (2006) 0.86
Favourable outcome of patients with childhood acute promyelocytic leukaemia after treatment with reduced cumulative anthracycline doses. Br J Haematol (2010) 0.86
Residual or recurrent cerebellar low-grade glioma in children after tumor resection: is re-treatment needed? A single center experience from 1983 to 2003. Pediatr Neurosurg (2006) 0.86
Once-per-cycle pegfilgrastim versus daily filgrastim in pediatric patients with Ewing sarcoma. J Pediatr Hematol Oncol (2005) 0.86
Liposomal cytarabine for leukemic and lymphomatous meningitis: recent developments. Expert Opin Pharmacother (2008) 0.86
Essential roles of Raf/extracellular signal-regulated kinase/mitogen-activated protein kinase pathway, YY1, and Ca2+ influx in growth arrest of human vascular smooth muscle cells by bilirubin. J Biol Chem (2012) 0.85
Biomaterials and mesenchymal stem cells for regenerative medicine. Recent Pat Biotechnol (2010) 0.85
Intracranial reparative giant cell granuloma secondary to cholesteatoma in a 15-year-old girl. J Pediatr Hematol Oncol (2008) 0.85
Childhood pineoblastoma: experiences from the prospective multicenter trials HIT-SKK87, HIT-SKK92 and HIT91. J Neurooncol (2006) 0.84
Neuroophthalmological side effects following intrathecal administration of liposomal cytarabine for central nervous system prophylaxis in three adolescents with acute myeloid leukaemia. Ann Hematol (2008) 0.84
Management of brain abscesses in children treated for acute lymphoblastic leukemia. Pediatr Blood Cancer (2009) 0.84
The bile acid synthesis pathway is present and functional in the human ovary. PLoS One (2009) 0.84
A scoring system to quantify late effects in children after treatment for medulloblastoma/ependymoma and its correlation with quality of life and neurocognitive functioning. Childs Nerv Syst (2008) 0.84
Discovery of a potent and selective free fatty acid receptor 1 agonist with low lipophilicity and high oral bioavailability. J Med Chem (2013) 0.83
The spectrum of parvovirus b19 infection in a pediatric hemato-oncologic ward. Pediatr Infect Dis J (2011) 0.82
Safety and toxicity of intrathecal liposomal cytarabine (Depocyte) in children and adolescents with recurrent or refractory brain tumors: a multi-institutional retrospective study. Anticancer Drugs (2009) 0.82
Pheochromocytoma in a 2.75-year-old-girl with a germline von Hippel-Lindau mutation Q164R. Am J Med Genet A (2010) 0.82
Low-dose versus high-dose immunoglobulin for primary treatment of acute immune thrombocytopenic purpura in children: results of a prospective, randomized single-center trial. J Pediatr Hematol Oncol (2003) 0.82
Non-infectious causes of elevated procalcitonin and C-reactive protein serum levels in pediatric patients with hematologic and oncologic disorders. Support Care Cancer (2008) 0.82
Immune reconstitution after purified autologous and allogeneic blood stem cell transplantation compared with unmanipulated bone marrow transplantation in children. Br J Haematol (2006) 0.82
Effects of cadmium chloride on some mitochondria-related activity and gene expression of human MDA-MB231 breast tumor cells. J Inorg Biochem (2008) 0.82
Ependymoma of the spinal cord in children and adolescents: a retrospective series from the HIT database. J Neurosurg Pediatr (2010) 0.82
High response rate but short-term effect of romiplostim in paediatric refractory chronic immune thrombocytopenia. Br J Haematol (2014) 0.81
Cadmium effects on p38/MAPK isoforms in MDA-MB231 breast cancer cells. Biometals (2009) 0.81
Malignant non-Hodgkin's lymphoma of childhood and adolescence in Austria--therapy results between 1986 and 2000. Wien Klin Wochenschr (2002) 0.81
Long-term outcomes of hematopoietic stem cell transplantation for severe treatment-resistant autoimmune cytopenia in children. Biol Blood Marrow Transplant (2012) 0.81
Age- and gender-related differences in teicoplanin levels in paediatric patients. J Antimicrob Chemother (2013) 0.80
Transplantation of highly purified CD34+ progenitor cells from alternative donors in children with refractory severe aplastic anaemia. Br J Haematol (2004) 0.80
Clinical, radiological, and pathological findings in four children with gastrointestinal stromal tumors of the stomach. Pediatr Hematol Oncol (2007) 0.80
Chromosomal integration of the HHV-6 genome in a patient with nodular sclerosis Hodgkin lymphoma. Br J Haematol (2013) 0.80
Bone marrow necrosis in a girl with Hodgkin's disease. Support Care Cancer (2012) 0.79
Tumor cell-collagen interactions: Identification and semi-quantitative evaluation of selectively-expressed genes by combination of differential display- and multiplex-PCR. Biol Proced Online (2003) 0.79
Cytotoxic effects of Jay Amin hydroxamic acid (JAHA), a ferrocene-based class I histone deacetylase inhibitor, on triple-negative MDA-MB231 breast cancer cells. Chem Res Toxicol (2012) 0.79
Early and reliable diagnosis of non-Hodgkin lymphoma in childhood and adolescence: contribution of cytomorphology and flow cytometric immunophenotyping. Pediatr Hematol Oncol (2006) 0.78
Numb chin syndrome as initial manifestation in a child with acute lymphoblastic leukemia. Pediatr Blood Cancer (2008) 0.78
Cardiac and pulmonary late effects do not negatively influence performance status and non-relapse mortality of children surviving five yr after autologous hematopoietic cell transplantation: report from the EBMT Paediatric Diseases and Late Effects Working Parties. Pediatr Transplant (2008) 0.78
Induction of xenograft accommodation by modulation of elicited antibody responses1 2. Transplantation (2002) 0.78
Subphthalocyanine-based nanocrystals. Chem Commun (Camb) (2011) 0.78
Short-term intravenous fish-oil emulsions in pediatric oncologic patients--effect on liver parameters. Nutr Cancer (2014) 0.78
Long-term Remission in a Female With Multiple Relapsed Juvenile Granulosa Cell Tumor. J Pediatr Hematol Oncol (2015) 0.77
Effect of transfection with PLP2 antisense oligonucleotides on gene expression of cadmium-treated MDA-MB231 breast cancer cells. Anal Bioanal Chem (2012) 0.77
Cadmium regulation of apoptotic and stress response genes in tumoral and immortalized epithelial cells of the human breast. Biochimie (2008) 0.77
Peripheral blood stem cell mobilization with pegfilgrastim compared to filgrastim in children and young adults with malignancies. Pediatr Blood Cancer (2010) 0.77
Design, characterization and cellular uptake studies of fluorescence-labeled prototypic cathepsin inhibitors. Org Biomol Chem (2015) 0.77
Partial splenic embolization in children with hereditary spherocytosis. Eur J Haematol (2007) 0.77
Unrelated CD3/CD19-depleted peripheral stem cell transplantation for Hurler syndrome. Pediatr Hematol Oncol (2014) 0.77
Retinoblastoma: a proposal for a multimodal treatment concept for intraocular retinoblastoma in Austria. Wien Klin Wochenschr (2006) 0.77
Mitochondrial compartment: a possible target of cadmium effects on breast epithelial cells. Mol Cell Biochem (2009) 0.77
Medulloblastoma in a child with down syndrome: long-term remission with multimodality treatment. Pediatr Blood Cancer (2009) 0.76
Transmission of chromosomally integrated HHV-6 by bone marrow transplantation. Pediatr Blood Cancer (2011) 0.76
Artificial scaffolds and mesenchymal stem cells for hard tissues. Adv Biochem Eng Biotechnol (2012) 0.76
Mid-region parathyroid hormone-related protein (PTHrP) and gene expression of MDA-MB231 breast cancer cells. Biol Chem (2007) 0.76
Mid-region parathyroid hormone-related protein (PTHrP) binds chromatin of MDA-MB231 breast cancer cells and isolated oligonucleotides "in vitro". Breast Cancer Res Treat (2006) 0.76
Add-on-therapy with bevacizumab in children and adolescents with poor prognosis non-CNS solid tumors. Anticancer Drugs (2013) 0.76
Cytogenetic characterization of HB2 epithelial cells from the human breast. In Vitro Cell Dev Biol Anim (2013) 0.76
Severe epstein-barr virus encephalitis with hemophagocytic syndrome: rapid clearance of virus following allogeneic hematopoietic stem cell transplantation from a seropositive donor. Pediatr Infect Dis J (2010) 0.76
A novel immunodeficiency syndrome associated with partial trisomy 19p13. J Med Genet (2014) 0.76
Long-term use of anagrelide in the treatment of children with essential thrombocythemia. Eur J Haematol (2006) 0.76
PTHrP in differentiating human mesenchymal stem cells: transcript isoform expression, promoter methylation, and protein accumulation. Biochimie (2013) 0.76